ask="25.00"
ask_size="500"
average_daily_volume="423159"
bid="19.00"
bid_size="300"
book_value="3.21"
change="-0.99"
change_from_200_day_moving_average="5.92"
change_from_50_day_moving_average="0.62"
change_from_52_week_high="-3.13"
change_From_52_week_low="14.76"
change_in_percent="-4.58%"
close="20.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="21.62"
high_52_weeks="23.75"
last_trade_date="3/6/2017"
last_trade_price="20.62"
last_trade_size="3039"
last_trade_time="4:00pm"
low="20.57"
low_52_weeks="5.86"
market_capitalization="205.23M"
moving_average_200_day="14.70"
moving_average_50_day="20.00"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="21.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+40.22%"
percent_change_from_50_day_moving_average="+3.09%"
percent_change_from_52_week_high="-13.18%"
percent_change_from_52_week_low="+251.88%"
previous_close="21.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.74"
price_per_sales="3805.19"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.00"
stock_exchange="NGM"
symbol="ZYNE"
volume="346600"
weeks_range_52="5.86 - 23.75"
